Who to Register...

The BAD Biologic Interventions Register has 2 psoriasis patient cohorts:

(i) for patients receiving Biologic Therapy and (ii) for patients being treated with Conventional Anti-Psoriatic Systemics

To be eligible to join BADBIR patients must be receving a biologic or conventional treatment for therapy of their psoriasis and meet the following criteria:

Biologic Cohort

• - The patient must have started or switched to a biologic therapy within 6 months of registration on the database
• - Biologic therapies are: adalimumab, etanercept, infliximab and ustekinumab
• - The patient must over 16 years of age
• - Consent must be provided by the patient to join BADBIR
• Download Biologic Cohort Eligibility Poster

Conventional Cohort

• - The patient must have started or switched to a conventional therapy within 6 months of registration on the database
• - Conventional therapies are: acitretin, ciclosporin, fumaric acid esters, hydroxycarbamide, methotrxate and PUVA
• - The PASI must be greater than or equal to 10 and the DLQI greater than 10 (this does not apply if the patient is switching between conventional therapies)
• - The patient must be naïve to biologic therapy
• - Consent must be provided by the patient to join BADBIR
• Download Conventional Cohort Eligibility Poster